The scarcity of available human lung specimens, compounded by the paucity of animal models, has considerably constrained the scope of investigations into the underlying pathogenic mechanisms governing the development of RP‐ILD in anti‐MDA5+ DM, thereby underscoring the critical urgency and significance of advancing research in this domain. This evidence concerns the gene IFIH1 and interstitial lung disease.